Penson RT, Valencia RV, Cibula D, Colombo N, et al. Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial. J Clin Oncol 2020 Feb 19:JCO1902745. doi: 10.1200/JCO.19.02745.
PMID: 32073956